Aeroflow Healthcare, a nationwide durable medical equipment (DME) provider, and its Industrial Division, issued a statement with its support of Senator Chuck Schumer’s comments regarding the U.S. Department of Transportation’s withdrawal of support for a sleep apnea testing requirement.
Aeroflow industrial manager Michael Trufant says in a release, “Senator Schumer is spot-on about how easy the conclusion should be to reinstate the rulemaking process when looking at the facts about sleep apnea. This is a clear and present danger on our roads, rails, and highways. Our traveling public should not be exposed to danger on their commutes. So far, the arguments made against obstructive sleep apnea (OSA) testing and treatment for rail and truck drivers have focused exclusively on the cost of testing and treatment, not on safety. The cost is minimal. The safety imperative is pressing. The National Transportation Safety Board has consistently called for it. This is an opportunity to ensure public safety, and without this requirement, we are instead choosing to neglect it.”
